PKR activity modulation by phosphomimetic mutations of serine residues located three aminoacids upstream of double-stranded RNA binding motifs

[1]  Ryan L. Collins,et al.  The mutational constraint spectrum quantified from variation in 141,456 humans , 2020, Nature.

[2]  Yong Sun Lee,et al.  Protein kinase R and its cellular regulators in cancer: An active player or a surveillant? , 2020, Wiley interdisciplinary reviews. RNA.

[3]  D. Vertommen,et al.  Methionine sulfoxide reductase B from Corynebacterium diphtheriae catalyzes sulfoxide reduction via an intramolecular disulfide cascade , 2020, The Journal of Biological Chemistry.

[4]  T. Michiels,et al.  The Leader Protein of Theiler's Virus Prevents the Activation of PKR , 2019, Journal of Virology.

[5]  Zhaocai Zhou,et al.  Structure and Degradation of Circular RNAs Regulate PKR Activation in Innate Immunity , 2019, Cell.

[6]  Martin Eisenacher,et al.  The PRIDE database and related tools and resources in 2019: improving support for quantification data , 2018, Nucleic Acids Res..

[7]  J. Neyts,et al.  Species Specificity of Type III Interferon Activity and Development of a Sensitive Luciferase-Based Bioassay for Quantitation of Mouse Interferon-λ , 2018, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[8]  E. Freundt,et al.  Innate Immune Detection of Cardioviruses and Viral Disruption of Interferon Signaling , 2018, Front. Microbiol..

[9]  D. Duffy,et al.  Mitochondrial double-stranded RNA triggers antiviral signalling in humans , 2018, Nature.

[10]  D. Vertommen,et al.  HBP1 phosphorylation by AKT regulates its transcriptional activity and glioblastoma cell proliferation. , 2018, Cellular signalling.

[11]  C. Rice,et al.  Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown , 2018, Cell.

[12]  G. Maarifi,et al.  Differential effects of SUMO1 and SUMO3 on PKR activation and stability , 2018, Scientific Reports.

[13]  Y. Jacob,et al.  Inhibition of the inflammatory response to stress by targeting interaction between PKR and its cellular activator PACT , 2017, Scientific Reports.

[14]  H. Boulaiz,et al.  Clinical and therapeutic potential of protein kinase PKR in cancer and metabolism , 2017, Expert Reviews in Molecular Medicine.

[15]  B. Williams,et al.  Auto-phosphorylation Represses Protein Kinase R Activity , 2017, Scientific Reports.

[16]  G. Conn,et al.  Human noncoding RNA 886 (nc886) adopts two structurally distinct conformers that are functionally opposing regulators of PKR , 2017, RNA.

[17]  G. Hartmann,et al.  Discriminating self from non-self in nucleic acid sensing , 2016, Nature Reviews Immunology.

[18]  Andrew S. Dixon,et al.  NanoLuc Complementation Reporter Optimized for Accurate Measurement of Protein Interactions in Cells. , 2016, ACS chemical biology.

[19]  Wang Wj,et al.  PKR and HMGB1 expression and function in rheumatoid arthritis. , 2015 .

[20]  Y. Crow,et al.  Aicardi–Goutières syndrome and the type I interferonopathies , 2015, Nature Reviews Immunology.

[21]  Madhusudan Dey,et al.  Activation of Protein Kinase PKR Requires Dimerization-induced cis-Phosphorylation within the Activation Loop* , 2013, The Journal of Biological Chemistry.

[22]  Z. Fehérvári.  Viral infection: the clot thickens , 2012, Nature Immunology.

[23]  T. Maeda,et al.  Stress granules , 2012, Cell cycle.

[24]  Yong Sun Lee,et al.  Precursor miR-886, a novel noncoding RNA repressed in cancer, associates with PKR and modulates its activity. , 2011, RNA.

[25]  Rekha C. Patel,et al.  Stress-induced phosphorylation of PACT reduces its interaction with TRBP and leads to PKR activation. , 2011, Biochemistry.

[26]  M. Mann,et al.  System-Wide Temporal Characterization of the Proteome and Phosphoproteome of Human Embryonic Stem Cell Differentiation , 2011, Science Signaling.

[27]  F. V. van Kuppeveld,et al.  Random Mutagenesis Defines a Domain of Theiler's Virus Leader Protein That Is Essential for Antagonism of Nucleocytoplasmic Trafficking and Cytokine Gene Expression , 2009, Journal of Virology.

[28]  P. Anderson,et al.  Stress granules , 2009, Current Biology.

[29]  B. Williams,et al.  The role of PACT in mediating gene induction, PKR activation, and apoptosis in response to diverse stimuli. , 2008, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[30]  A. Gatignol,et al.  Interactions between the double-stranded RNA-binding proteins TRBP and PACT define the Medipal domain that mediates protein-protein interactions , 2008, RNA biology.

[31]  A. Bode,et al.  Involvement of ERKs, RSK2 and PKR in UVA-induced signal transduction toward phosphorylation of eIF2alpha (Ser(51)). , 2007, Carcinogenesis.

[32]  E. Meurs,et al.  The dsRNA protein kinase PKR: virus and cell control. , 2007, Biochimie.

[33]  Yu Pan,et al.  RAX, the PKR activator, sensitizes cells to inflammatory cytokines, serum withdrawal, chemotherapy, and viral infection. , 2006, Blood.

[34]  Arvin C. Dar,et al.  Mechanistic Link between PKR Dimerization, Autophosphorylation, and eIF2α Substrate Recognition , 2005, Cell.

[35]  P. Walter,et al.  Basis for regulated RNA cleavage by functional analysis of RNase L and Ire1p. , 2001, RNA.

[36]  A. Hinnebusch,et al.  Hepatitis C Virus Envelope Protein E2 Does Not Inhibit PKR by Simple Competition with Autophosphorylation Sites in the RNA-Binding Domain , 2001, Journal of Virology.

[37]  S. Nanduri,et al.  A dynamically tuned double‐stranded RNA binding mechanism for the activation of antiviral kinase PKR , 2000, The EMBO journal.

[38]  N. Sonenberg,et al.  The Murine Double-Stranded RNA-Dependent Protein Kinase PKR Is Required for Resistance to Vesicular Stomatitis Virus , 2000, Journal of Virology.

[39]  P. Roberts,et al.  Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection. , 2000, Immunity.

[40]  Mingli Yang,et al.  RAX, a Cellular Activator for Double-stranded RNA-dependent Protein Kinase during Stress Signaling* , 1999, The Journal of Biological Chemistry.

[41]  M. Katze,et al.  Inhibition of Double-Stranded RNA-Dependent Protein Kinase PKR by Vaccinia Virus E3: Role of Complex Formation and the E3 N-Terminal Domain , 1998, Molecular and Cellular Biology.

[42]  B. Williams,et al.  Structure of the double‐stranded RNA‐binding domain of the protein kinase PKR reveals the molecular basis of its dsRNA‐mediated activation , 1998, The EMBO journal.

[43]  G. Sen,et al.  PACT, a protein activator of the interferon‐induced protein kinase, PKR , 1998, The EMBO journal.

[44]  T. Michiels,et al.  Adaptation of Theiler's virus to L929 cells: mutations in the putative receptor binding site on the capsid map to neutralization sites and modulate viral persistence. , 1998, Virology.

[45]  T. Michiels,et al.  Protein 2A is not required for Theiler's virus replication , 1997, Journal of virology.

[46]  Shiyong Wu,et al.  A Model for the Double-stranded RNA (dsRNA)-dependent Dimerization and Activation of the dsRNA-activated Protein Kinase PKR* , 1997, Journal of Biological Chemistry.

[47]  T. Cech,et al.  Minor-groove recognition of double-stranded RNA by the double-stranded RNA-binding domain from the RNA-activated protein kinase PKR. , 1996, Biochemistry.

[48]  M. Katze,et al.  Interaction of the interferon-induced PKR protein kinase with inhibitory proteins P58IPK and vaccinia virus K3L is mediated by unique domains: implications for kinase regulation , 1996, Molecular and cellular biology.

[49]  W. Toone,et al.  Mutational Analysis of the Double-stranded RNA (dsRNA) Binding Domain of the dsRNA-activated Protein Kinase, PKR (*) , 1995, The Journal of Biological Chemistry.

[50]  A. Hinnebusch,et al.  Structural requirements for double-stranded RNA binding, dimerization, and activation of the human eIF-2 alpha kinase DAI in Saccharomyces cerevisiae , 1995, Molecular and cellular biology.

[51]  E. Paoletti,et al.  TAR RNA-binding protein is an inhibitor of the interferon-induced protein kinase PKR. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[52]  S. B. Lee,et al.  The interferon-induced double-stranded RNA-activated protein kinase induces apoptosis. , 1994, Virology.

[53]  C. Samuel,et al.  Mechanism of interferon action: cDNA structure, expression, and regulation of the interferon-induced, RNA-dependent P1/eIF-2 alpha protein kinase from human cells. , 1992, Virology.

[54]  M. Katze,et al.  Functional expression and RNA binding analysis of the interferon-induced, double-stranded RNA-activated, 68,000-Mr protein kinase in a cell-free system , 1991, Molecular and cellular biology.

[55]  I. Kerr,et al.  Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon , 1990, Cell.

[56]  J. Miller,et al.  Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system , 1987, Molecular and cellular biology.

[57]  R. Jackson,et al.  Phosphorylation of initiation factor eIF-2 and the control of reticulocyte protein synthesis , 1977, Cell.

[58]  M. Mathews,et al.  The regulation of the protein kinase PKR by RNA. , 1996, Biochimie.